Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Infection-related arthritis
How do you focus your history and exam to better identify potential cases of chikungunya presenting with rheumatic symptomas in the setting of global travel?
Related Questions
What strategies do you implement in your clinic to ensure comprehensive screening and timely diagnosis of syphilis in populations with risk factors for sexually transmitted infections?
What specific criteria or patient conditions would make you hesitant to use fluoroquinolones early in the treatment course for managing MSSA joint infections with oral antibiotics?
How often do you see bony erosions in patients with Lyme arthritis?
How do you integrate next-generation sequencing with traditional culture methods to improve the identification of fungal pathogens, especially in cases where routine cultures are negative when evaluating suspected prosthetic joint infections?
How do you differentiate between chikungunya-induced arthritis and RA during sporadic outbreaks or in regions with higher prevalence?
How would you manage cardiac sarcoid with intolerance/contraindications to methotrexate, azathioprine, and mycophenolate/mycophenolic acid and that has proven refractory to adalimumab and infliximab as determined by PET?
How do you approach discussing the pill burden of voclosporin with patients who already have to take a regimen such as MMF+HCQ+ACEi and possibly more?
How would you manage a patient on tocilizumab for recently diagnosed severe GCA who developed a bowel obstruction several weeks after the first dose of Tocilizumab?
What is your treatment approach for a young female who has an idiopathic small right elbow effusion with synovial thickening that has resulted in limitation in her range of motion?
How do you approach the management of patients with suspected membranous lupus nephritis who are found to have positive PLA2R antibodies?
